Arkolith/Insider Trading/ITRM/Form 4

Dunne Michael W.

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Nov 27, 2023
Net Buying
Open-Market Buys
$41K
Open-Market Sells
$0
Net Open-Market Flow
$41K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2023Buy(P)20K$2.03$41K79K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056685) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML